Market Cap

Annexin Pharmaceuticals AB Market Capitalization:

kr69.5 Million

SEK as of Jan. 1, 2024

US$6.9 Million

business Annexin Pharmaceuticals AB Company Profile

Annexin Pharmaceuticals AB Main Stock Listing

OMX: ANNX

Market Capitalization History of Annexin Pharmaceuticals AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Annexin Pharmaceuticals AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr69.5 M -60.03%
Jan. 1, 2023 kr173.8 M 23.97%
Jan. 1, 2022 kr140.2 M -47.53%
Jan. 1, 2021 kr267.2 M 33.21%
Jan. 1, 2020 kr200.6 M 12.37%
Jan. 1, 2019 kr178.5 M -68.04%
Jan. 1, 2018 kr558.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Annexin Pharmaceuticals AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Annexin Pharmaceuticals AB has the following listings and related stock indices.


Stock: OMX: ANNX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.